InvestorsHub Logo
Followers 546
Posts 8130
Boards Moderated 3
Alias Born 10/23/2016

Re: ehihub post# 19627

Thursday, 08/27/2020 10:32:53 AM

Thursday, August 27, 2020 10:32:53 AM

Post# of 197087
..thanks. This one i think is one of those extremely rare super cheap penny biotechs...with completed Phase III trials done in the E.U.

but......The pps doesnt make sense, im sorry.....at all. No not for a Phase IV drug.

- we all could find comparable biotechs whose MC is in hundreds of millions of dollars or even tens of miilons who have NOT passed even Phase II yet.

...and being that im Up North on rare vaca i have to leave it at that. But the immense dd possible here, on a 15;year tested drug that works at a high rate, 80% vs, HIV ...and most excitingly of all they are opening up ImmunH to be listed as an Immune Modulator and fight ALL other viruses cause during the Trials if you read the papers....cause they found out during the Trials that ImmunH ALSO did so good vs other viruses,....(!!)

.001 ....002....then .003 break next hurdles, and of course big Signal to biotech traders and investors ....: should be exciting here for awhile, especially cause this is highly efficient in its virus killing abilities YET safe for use.....and not like the dime a dozen drugs and biotechs out there that hopefully will pass Trials one day....





.....ENZC already has.....